UOS2_main_wide_title3.jpg
UOS1_home_web.jpg
uos-borrelia.png
UOS2_main_wide_title3.jpg
SCROLL DOWN

UNDER OUR SKIN 2: EMERGENCE

Academy Award semifinalist UNDER OUR SKIN brought unprecedented awareness to the shocking story of Lyme disease, an often-chronic condition many doctors claimed was “all in your head."  Since then, the CDC has upped its estimate of annual cases by ten times, making Lyme disease more prevalent than HIV and breast cancer combined.  This highly-anticipated sequel investigates the deepening Lyme disease crisis and follows its casualties and controversies.  As the Lyme epidemic explodes globally, scandalous medical collusions and conflicts of interest incriminate the very healthcare systems meant to protect us.  Despite the obstacles that researchers, physicians and patients continue to face, promising new findings are emerging.  And when we revisit the unforgettable characters from UNDER OUR SKIN, we see that they have moved from horror to hope, arriving at better health and reclaiming their lives.  More...

UOS1_home_web.jpg

Under Our Skin


"Eye-opening...frightening...powerful." 
– Los Angeles Times

SCROLL DOWN

Under Our Skin


"Eye-opening...frightening...powerful." 
– Los Angeles Times

UNDER OUR SKIN: DIRECTOR'S CUT

A chilling tale of microbes, medicine and money, this Oscar shortlisted film has changed the landscape of the Lyme epidemic, bringing unprecedented awareness in an engaging and accessible way. The definitive record of the Lyme controversy, UNDER OUR SKIN exposes a hidden story of medical and scientific malfeasance and neglect.  As official case numbers explode and hundreds of thousands of people around the world go undiagnosed or misdiagnosed, the film is as relevant and timely as ever.

The newly released Director's Cut includes 15-minutes of restored footage, re-edited scenes and character updates. More...

uos-borrelia.png

Store


"Like a well made thriller...gets under your skin."
– Washington Post

SCROLL DOWN

Store


"Like a well made thriller...gets under your skin."
– Washington Post